Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Healthstream (HSTM) over the last 17 years, with Q3 2025 value amounting to $53.5 million.

  • Healthstream's Cash & Equivalents fell 686.22% to $53.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.5 million, marking a year-over-year decrease of 686.22%. This contributed to the annual value of $59.5 million for FY2024, which is 4744.5% up from last year.
  • Latest data reveals that Healthstream reported Cash & Equivalents of $53.5 million as of Q3 2025, which was down 686.22% from $52.1 million recorded in Q2 2025.
  • In the past 5 years, Healthstream's Cash & Equivalents ranged from a high of $77.3 million in Q1 2025 and a low of $25.8 million during Q2 2023
  • For the 5-year period, Healthstream's Cash & Equivalents averaged around $48.9 million, with its median value being $48.3 million (2022).
  • Per our database at Business Quant, Healthstream's Cash & Equivalents tumbled by 5778.64% in 2021 and then soared by 7876.77% in 2024.
  • Quarter analysis of 5 years shows Healthstream's Cash & Equivalents stood at $46.9 million in 2021, then decreased by 1.88% to $46.0 million in 2022, then dropped by 12.36% to $40.3 million in 2023, then surged by 47.45% to $59.5 million in 2024, then fell by 9.96% to $53.5 million in 2025.
  • Its Cash & Equivalents stands at $53.5 million for Q3 2025, versus $52.1 million for Q2 2025 and $77.3 million for Q1 2025.